ePrints

The thiopurines: An update

Lookup NU author(s): Dr Sally Coulthard, Dr Linda Hogarth

Downloads

Full text for this publication is not currently held within this repository. Alternative links are provided below where available.

Abstract

The thiopurine drugs, 6-mercaptopurine (6-MP), 6-thioguanine (6-TG) are commonly used cytotoxic agents. A derivative of 6-MP, azathioprine, is commonly used as an immunosuppressant. A prominent route for the metabolism of these agents is mediated by the enzyme thiopurine methyltransferase (TPMT). This enzyme exhibits considerable inter-individual variation in activity, partly due to the presence of common genetic polymorphisms, which influence cytotoxicity of the thiopurine drugs. Variations in the number of tandem repeats in the 5' promoter region have also been shown to influence TPMT expression in vitro. In this article, we review the impact of variations in TPMT activity on sensitivity to the thiopurine drugs in vitro and also in vivo in terms of their clinical efficacy and toxicity. A possible relationship between TPMT and secondary malignancies is also reviewed.

Publication metadata

Author(s): Coulthard SA, Hogarth LA

Publication type: Review

Publication status: Published

Journal: Investigational New Drugs

Year: 2005

Volume: 23

Issue: 6

Pages: 523-532

ISSN (print): 0167-6997

ISSN (electronic): 1573-0646

URL: http://dx.doi.org/10.1007/s10637-005-4020-8

DOI: 10.1007/s10637-005-4020-8

PubMed id: 16267626

Share